Effects of α-melanocyte-stimulating hormone on calcium concentration in SZ95 sebocytes

Experimental Dermatology

Volumn 20, Issue 1, 2011, Pages 19-23

  Whang, Sung Won ^a   Lee, Sang Eun ^a   Kim, Ji Min ^a   Kim, Hyun Jung ^a   Jeong, Se Kyoo ^b   Zouboulis, Christos C ^c,d   Seo, Jeong Taek ^e   Lee, Seung Hun ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Research Division   (South Korea)

^c DESSAU MEDICAL CENTER   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e Yonsei University College of Dentistry   (South Korea)

Author keywords

MSH; Calcium; SZ95 sebocyte

Indexed keywords

ALPHA INTERMEDIN; CALCIUM; INOSITOL TRISPHOSPHATE; MELANOCORTIN 1 RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOREACTIVITY; LIPOGENESIS; PROTEIN EXPRESSION; SEBACEOUS CELL; SEBUM; SIGNAL TRANSDUCTION; SKIN CELL;

ALPHA-MSH; CALCIUM SIGNALING; CELL LINE; HUMANS; LIPIDS; RECEPTOR, MELANOCORTIN, TYPE 1; SEBACEOUS GLANDS; SEBUM; TESTOSTERONE;

EID: 78650216364     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2010.01199.x     Document Type: Article

References (36)

1. Slominski A, Wortsman J. Endocr Rev 2000: 21: 457-487.
2. Slominski A, Wortsman J, Luger T et al. Physiol Rev 2000: 80: 979-1020.
3. Slominski A, Zbytek B, Zmijewski M et al. Front Biosci 2006: 11: 2230-2248.
4. Zouboulis C C, Böhm M. Exp Dermatol 2004: 13 (Suppl 4): 31-35.
5. Zouboulis C C. Clin Dermatol 2004: 22: 360-366.
6. Böhm M, Schiller M, Luger T A. Cell Mol Biol (Noisy-le-grand) 2006: 52: 61-68.
7. Slominski A, Tobin D J, Shibahara S et al. Physiol Rev 2004: 84: 1155-1228.
8. Schallreuter K U, Kothari S, Chavan B et al. Exp Dermatol 2008: 17: 395-404.
9. Gantz I, Shimoto Y, Konda Y et al. Biochem Biophys Res Commun 1994: 200: 1214-1220.
10. Böhm M, Luger T A, Tobin D J et al. J Invest Dermatol 2006: 126: 1966-1975.
11. Böhm M, Schiller M, Stander S et al. J Invest Dermatol 2002: 118: 533-539.
12. Zhang L, Li W H, Anthonavage M et al. Peptides 2006: 27: 413-420.
13. Berridge M J, Lipp P, Bootman M D. Nat Rev Mol Cell Biol 2000: 1: 11-21.
14. Clapham D E. Cell 1995: 80: 259-268.
15. Putney J W Jr, Broad L M, Braun F J et al. J Cell Sci 2001: 114: 2223-2229.
16. Sabatier N, Caquineau C, Douglas A J et al. Ann N Y Acad Sci 2003: 994: 218-224.
17. Elliott R J, Szabo M, Wagner M J et al. J Invest Dermatol 2004: 122: 1010-1019.
18. Eves P, Haycock J, Layton C et al. Br J Cancer 2003: 89: 2004-2015.
19. Zouboulis C C, Seltmann H, Neitzel H et al. J Invest Dermatol 1999: 113: 1011-1020.
20. Thio H B, Zomerdijk T P, Oudshoorn C et al. Br J Dermatol 1994: 131: 856-861.
21. Ganceviciene R, Graziene V, Böhm M et al. Exp Dermatol 2007: 16: 547-552.
22. García-Borrón J C, Sánchez-Laorden B L, Jiménez-Cervantes C. Pigment Cell Res 2005: 18: 393-410.
23. Slominski A, Wortsman J, Paus R et al. Drug Discov Today Dis Mech 2008: 5: e137-e144.
24. Slominski A, Paus R, Mazurkiewicz J. Experientia 1992: 48: 50-54.
25. Smalley K, Eisen T. FEBS Lett 2000: 476: 198-202.
26. Buggy J J. Biochem J 2000: 331: 211-216.
27. Buffey J A, Thody A J, Bleehen S S et al. J Endocrinol 1992: 133: 333-340.
28. MacNeil S, Dobson J, Bleehen S S et al. Br J Dermatol 1990: 123: 828.
29. Mountjoy K G, Kong P L, Taylor J A et al. Physiol Genomics 2001: 5: 11-19.
30. Hoogduijn M J, McGurk S, Smit N P et al. Biochem Biophys Res Commun 2002: 290: 844-850.
31. Konda Y, Gantz I, DelValle J et al. J Biol Chem 1994: 269: 13162-13166.
32. Montero M, Alonso M T, Carnicero E et al. Nat Cell Biol 2000: 2: 57-61.
33. Islam M S. Diabetes 2002: 51: 1299-1309.
34. Missiaen L, Callewaert G, De Smedt H et al. Cell Calcium 2001: 29: 111-116.
35. Berridge M J, Bootman M D, Roderick H L. Nat Rev Mol Cell Biol 2003: 4: 517-529.
36. Tóth B I, Géczy T, Griger Z et al. J Invest Dermatol 2009: 129: 329-339.